Nevertheless, this preliminary study can pave the way for further research with longer follow-up periods and larger patient cohorts, which allows a more precise mapping of the short- and long-term effects of SGLT-2 inhibitors on hydroxyl free radical formation, hormone resistance, and neuropathy. Here, SLC5A2 is linked to neuropathy.